Goodwin Procter advised Ai Build on the funding round. Ai Build, a London, UK-based additive manufacturing software company, raised $8.5M in Series A funding. The round...
Ai Build’s $8.5 Million Series A Funding
IBM’s Acquisition of Manta Software
Goodwin Procter advised Manta Software in its acquisition by IBM. IBM acquired Manta Software Inc – a world-class data lineage platform — to complement its capabilities within...
TitanML’s £2.3 Million Pre-Seed Round
Goodwin advised Octopus Ventures on their lead investment into TitanML. AI company, TitanML, has secured $2.8M in pre-seed funding led by Octopus Ventures alongside deep tech-focused...
In re GE ERISA Litigation
Robbins Geller Rudman & Dowd LLP, Block & Leviton and Gardy & Notis reached a $61 million settlement, pending final approval, in a case against General...
Kingswood Capital Management’s Acquisition of Covenant Testing Technologies
Goodwin Procter LLP and Grant Thornton advised Kingswood on the investment. Kingswood Capital Management, LP has acquired Covenant Testing Technologies, a well-flow management and equipment rental...
Breathe Battery’s $10 Million Series A Financing Round
Goodwin advised Lowercarbon Capital on the investment in Breathe Battery. Breathe Battery Technologies Limited secured a $10 million Series A funding round, led by Lowercarbon Capital...
Advanced Biologics’ Merger with Isto Biologics
Goodwin Procter advised Advanced Biologics in its merger with Isto Biologics. Isto Biologics, a portfolio company of TSCP and a global leader in regenerative and autologous...
Scholar Rock’s $92.5 Million Common Stock Offering
Goodwin advised Scholar Rock Holding Corporation on the offering. Scholar Rock Holding Corporation (Nasdaq: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious...
TwentyTwo Real Estate’s Acquisition of Majority Part of Center Parcs Allgäu
Goodwin assisted Batipart Immobilier Europe on the sale of the majority part of Center Parcs Allgäu to TwentyTwo Real Estate. Arendt & Medernach and Bryan Cave...
Royalty Pharma’s $1.5 Billion Acquisition of PTC Therapeutics’ Royalties
Fenwick & West, Goodwin Procter and Maiwald represented Royalty Pharma in the transaction, Wilmer Cutler Pickering Hale and Dorr represented PTC Therapeutics. Royalty Pharma plc (Nasdaq:...
Groupe Boiron’s Simplified Public Tender Offer
Ashurst advised BNP Paribas and CIC Lyonnaise de Banque in connection with the financing of the simplified takeover bid for the Boiron Group. Goodwin advised EW...
CMR Surgical’s $165 Million Funding Round
Goodwin advised CMR Surgical on the recent fundraising. CMR Surgical has raised $165 million in a round led by all of its major existing investors, including Ally Bridge...